Editorial

Current HIV Research begins its third volume providing our readers with stimulating, timely, and in-depth articles on current HIV and AIDS research. As the Editor-in-Chief, I take this opportunity to thank the authors who contributed their ideas and insights into each article. The manuscripts published in volumes 1 and 2 highlight a wide array of innovative scientific and medical research on HIV / AIDS. Beginning with the January, 2005 issue (Volume 3, Number 1), Current HIV Research will begin publishing original scientific articles on all areas of HIV and AIDS research. The journal will continue providing in-depth review articles, however, the journal is expanding to include primary scientific research at the request of authors and readers. The journal welcomes the submission of novel and pioneering work in the basic and clinical fields of virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV / AIDS vaccines and animal models, and prevention of viral infection. Current HIV Research aims to be the international journal for both comprehensive review articles and cutting-edge scientific findings on HIV research. The Editorial Advisory Board reflects the international representation of scientists and clinicians located in 14 different nations from some of the leading institutions in the world. We are proud that a similar diversity is reflected in the published and submitted articles as well. The journal fills a special void in the existing biomedical literature in publishing manuscripts focused on all areas of HIV / AIDS research including molecular biology, biochemistry, immunology, pharmacology, epidemiology, prevention of transmission, antiviral agents and vaccine development, as well as clinical research, which should be of interest to both basic and clinical investigators. We will continue to be responsive to our readers in order to build one of the leading research journal on HIV and AIDS research and we welcome your comments.